Top medical experts to grace Sidra conference

Sidra Medicine, a member of the Qatar Foundation for Education, Science and Community Development will bring together world-leading experts and practitioners from 10 countries for a symposium to accelerate advanced and experimental therapies.
The two day ‘Advanced Therapies Symposium’ starting from this Saturday at Four Seasons Doha, aims to share knowledge and research and spur innovation in advanced treatments ranging from cellular, gene therapy, molecular-targeted therapies and immunotherapy.
The conference will help ongoing research and drive scientific knowledge in the area of translational research and early clinical applications. It will shed light into the development phases, clinical trials, and regulatory aspects of these therapies, particularly in the field of Oncology, Haematology, Immunology, Inflammatory and Autoimmune disorders, to engender better and more personalised treatment options, and bring important health benefits.
Those interested in attending can register  at http://events.sidra.org/event/advanced-therapies-in-healthcare/  and a  limited number of spaces are available for on-site registration on both days.
The conference will feature leading figures and experts from the Middle East, Europe and the US. Key international speakers at the event include Soldano Ferrone, faculty member of the Department of Surgery at Massachusetts General Hospital, Harvard Medical School, Adrian Thrasher, professor of paediatric immunology at UCL Great Ormond Street Institute of Child Health, and Michele Maio, director of the Centre for Immuno-Oncology at University Hospital of Siena, amongst many others.
Providing a rich mixture of workshop sessions and keynote lectures, the conference is open to physicians, nurses, pharmacists, allied health providers, medical students and other practitioners who care for patients with oncological, haematological, immunology, inflammatory and autoimmune disorders. Attendees at the symposium can gain 14.75 Continuing Medical Education (CME) points since it is an Accredited Group Learning Activity (Category 1).
Dr Chiara Cugno, director, Clinic Research at Sidra Medicine said, “We are committed to creating effective platforms for healthcare professionals to collaborate, share best practices and methodologies and to developing programmes that advance personalised medicine in Qatar and beyond.
This conference is a critical part of our long-term goal to boost the introduction of advanced treatments, especially in cell and gene therapy in Qatar. It goes a long way towards supporting our ambition to introduce ground-breaking technologies and techniques that will significantly improve the lives of children, young people and women in the country.”